Teva Opposes Switching Asthma Drugs, Oral Contraceptives
This article was originally published in The Tan Sheet
Executive Summary
The firm’s opposition to allowing innovative switches for asthma drugs and oral contraceptives focuses on safety and consumers’ ability to self-select and manage their allergies or reproductive status, but maintains that Plan B One-Step and other emergency contraceptives are appropriate for full OTC status.
You may also be interested in...
Asthma Drug Petition Opposes OTC Approach, NSURE Paradigm
The developing Rx-to-nonprescription switch paradigm should exclude asthma and anaphylaxis drugs, advocates argue in a citizen petition. They say making inhalers available OTC contradicts the current standard for care.
Asthma Drug Petition Opposes OTC Approach, NSURE Paradigm
The developing Rx-to-nonprescription switch paradigm should exclude asthma and anaphylaxis drugs, advocates argue in a citizen petition. They say making inhalers available OTC contradicts the current standard for care.
Asthma Drug Petition Opposes OTC Approach, NSURE Paradigm
The developing Rx-to-nonprescription switch paradigm should exclude asthma and anaphylaxis drugs, advocates argue in a citizen petition. They say making inhalers available OTC contradicts the current standard for care.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: